Sign in

Ulcerative colitis: open trials in Brazil

13 open trials have a site in Brazil. Registry data; only the trial team decides who can take part.

  • NCT07158242

    A Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Afimkibart (RO7790121) in Children With Moderately to Severely Active Ulcerative Colitis

    Trial Treatment · Phase 3 · Hoffmann-La Roche

    CECIP - Centro de Estudos Clínicos do Interior Paulista, Jaú · Santa Casa de Misericordia de Porto Alegre, Porto Alegre · BR Trials - Pesquisa Clínica, São Paulo

    Registry updated 2026-11-05

  • NCT06937086

    Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

    Trial Treatment · Phase 3 · Eli Lilly and Company

    NewData Clinical Research - Aracaju, Aracaju · L2IP - Instituto de Pesquisas Clínicas, Brasília · Loema Instituto de Pesquisa Clinica, Campinas · Fundação Universidade de Caxias do Sul (FUCS), Caxias do Sul · Centro Digestivo de Curitiba, Curitiba · Galileo Medical Research, Juiz de Fora · Hospital de Clinicas de Porto Alegre, Porto Alegre · Hospital de Clínicas de Ribeirão Preto, Ribeirão Preto · CLIAGEN Clínica de Atenção em Gastroenterologia, Especialidades e Nutrição, Salvador · Pesquisare Saude, Santo André · CPQuali Pesquisa Clínica, São Paulo · CEPIC - Centro Paulista de Investigação Clínica, São Paulo · Clínica Hepatogastro JK, São Paulo · CEDOES, Vitória · Integral Pesquisa e Ensino, Votuporanga

    Registry updated 2026-11-04

  • NCT07186101

    LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:

    Trial Treatment · Phase 2 · Eli Lilly and Company

    Chronos Pesquisa Clínica, Brasília · CAEP - Synvia Labs, Campinas · Fundação Universidade de Caxias do Sul (FUCS), Caxias do Sul · Centro Digestivo de Curitiba, Curitiba · Galileo Medical Research, Juiz de Fora · NewData Clinical Research - Maceió, Maceió · Hospital Ernesto Dornelles, Porto Alegre · Centro Internacional de Pesquisa Clínica (CIPES), São José dos Campos · Clínica Hepatogastro JK, São Paulo · Solare Trials, São Paulo · CPQuali Pesquisa Clínica, São Paulo · Hospital Santa Catarina - Paulista, São Paulo · BRA - Clínica Médica e Terapia Assistida, Tajaí · Universidade Federal Do Piaui - Campos Universitario, Teresina

    Registry updated 2026-11-04

  • NCT07415044

    LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

    Trial Treatment · Phase 2 · Eli Lilly and Company

    Loema Instituto de Pesquisa Clinica, Campinas · Fundação Universidade de Caxias do Sul (FUCS), Caxias do Sul · HNSG, Curitiba · Centro de Oncologia Leonardo Da Vinci - ATO Terapias, Fortaleza · Hospital Ernesto Dornelles, Porto Alegre · Instituto D'Or de Pesquisa e Ensino (IDOR) - Filial Salvador, Salvador · Irmandade da Santa Casa da Misericórdia de Santos, Santos · Clínica Hepatogastro JK, São Paulo · BR Trials-Ensaios Clinicos e Consultoria, São Paulo · BRA - Clínica Médica e Terapia Assistida, Tajaí

    Registry updated 2026-11-04

  • NCT07483073

    A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

    Trial Treatment · Phase 2 · Eli Lilly and Company

    Loema Instituto de Pesquisa Clinica, Campinas · Fundação Universidade de Caxias do Sul (FUCS), Caxias do Sul · Centro Digestivo de Curitiba, Curitiba · Centro de Pesquisa Clínica de Marília - CPCLIM, Marília · CPCLIN, São Paulo · Clínica Hepatogastro JK, São Paulo · BR Trials-Ensaios Clinicos e Consultoria, São Paulo · CPHosp Medicina, Ensino e Pesquisa (CPQuali), São Paulo · CEDOES, Vitória

    Registry updated 2026-11-04

  • NCT06663332

    A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants

    Trial Treatment · Phase 3 · Janssen Research & Development, LLC

    Hospital das Clinicas - UFG, Goiânia · Integral Pesquisa e Ensino, Votuporanga

    Registry updated 2026-11-03

  • NCT07577856

    A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis

    Trial Treatment · Phase 3 · Janssen Research & Development, LLC

    Unesp - Faculdade de Medicina Da Universidade Estadual Paulista - Campus Botucatu, Botucatu · CDC - Centro Digestivo de Curitiba, Curitiba · CECIP Jau - Centro de Estudos Clínicos do Interior Paulista Ltda, Jaú · Liga Norte Riograndense Contra o Cancer, Natal · Complexo Hospitalar de Niteroi, Niterói · Hospital de Clinicas de Porto Alegre, Porto Alegre · Hospital Ernesto Dornelles, Porto Alegre · Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto, Ribeirão Preto · Pesquisare Saude, Santo André · Rocco And Nazato Servicos Medicos Ltda, São Paulo · Solare Trials, São Paulo · BR Trials, São Paulo · Integral Pesquisa e Ensino, Votuporanga

    Registry updated 2026-11-03

  • NCT07652294

    Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD

    Trial Treatment · Phase 2 · Spyre Therapeutics, Inc.

    Passo Fundo · Santo André

    Registry updated 2026-11-03

  • NCT06619990

    Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis

    Trial Treatment · Phase 1/2 · Xencor, Inc.

    Campinas · Caxias do Sul · Fortaleza · Macaé · Porto Alegre · Salvador · Santo André · São Paulo · Votuporanga

    Registry updated 2026-10-30

  • NCT06979336

    A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)

    Trial Treatment · Phase 2 · Genentech, Inc.

    Newdata Clinical Trials, Aracaju · Hospital Felicio Rocho, Belo Horizonte · Chronos Pesquisa Clínica, Brasília · L2IP - Instituto de Pesquisas Clínicas Ltda, Brasília · Centro Digestivo de Curitiba, Curitiba · Associao Paranaense de Cultura APC, Curitiba · HUWC - UFC - Hospital Universitrio Walter Cantdio - Universidade Federal do Cear, Fortaleza · CECIP - Centro de Estudos Clínicos do Interior Paulista, Ja · Hospital Ernesto Dornelles, Porto Alegre · Hospital de Clnicas de Porto Alegre, Porto Alegre · Hospital Gloria DOr - Hospitais Integrados da Gavea S/A, Rio de Janeiro · Pesquisare Saude, Santo André · Kaiser Clinica, São Jose Do Rio Preto · Instituto de Assistencia Medica ao Servidor Publico Estudo Estadual, São Paulo · BR Trials - Ensaios Clnicos e Consultoria, São Paulo · CPQuali Pesquisa Clinica Ltda, So Paulo

    Registry updated 2026-10-27

  • NCT07012395

    A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

    Trial Treatment · Phase 2 · Spyre Therapeutics, Inc.

    Barretos · Brasília · Campinas · Caxias do Sul · Consolação · Goiânia · Jaú · Juiz de Fora · Passo Fundo · Passo Fundo · Porto Alegre · Porto Alegre · Santo André · Santos · São José do Rio Preto · São Paulo · São Paulo · Teresina

    Registry updated 2026-10-27

  • NCT07071519

    A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis

    Trial Treatment · Phase 3 · AbbVie

    Hospital Pequeno Principe /ID# 271814, Curitiba · Galileo Medical Research /ID# 271817, Juiz de Fora · Hospital Sirio Libanes - Sao Paulo /ID# 271818, São Paulo

    Registry updated 2026-10-27

  • NCT04844606

    A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

    Trial Treatment · Phase 3 · Eli Lilly and Company

    Centro de Pesquisa Sao Lucas, Campinas · Hospital Pequeno Príncipe / Associação Hospitalar de Proteção à Infância, Curitiba · Universidade Federal de Goias, Goiânia · Hospital de Clinicas de Porto Alegre, Porto Alegre · Irmandade Da Santa Casa de Misericordia de Porto Alegre, Porto Alegre · Hospital Universitário Cassiano Antônio de Moraes, Vitória · Integral Pesquisa e Ensino, Votuporanga

    Registry updated 2026-10-07

All Ulcerative colitis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Ulcerative colitis trials in Brazil – Frontlight Research